fda glp-1 compounding crackdown news october 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA is moving to restrict

Mir Ali, MD, is a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center

Small, frequent meals may be better tolerated than larger portions given the gastric effects of these medications

Avril Beckford, retired chief of Wellstar Pediatrics, was celebrated and honored with the Physician of the Year Lifetime Achievement Award

Together, these principles prevent the four most common failure patterns seen in GLP-1 users: Fatigue from inadequate protein and micronutrient intake Muscle loss from caloric restriction without sufficient protein Digestive disruption from low fiber and dehydration Metabolic slowdown from losing muscle mass during rapid weight loss GLP-1 medications are a meaningful clinical tool for weight management

For each one of the effects they dig into, they come to different explanations for how the drugs help